Janney Starts Marker Therapeutics (MRKR) at Buy

March 1, 2019 6:03 AM EST Send to a Friend
Janney analyst Yun Zhong initiates coverage on Marker Therapeutics ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login